GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
Fierce Pharma
FEBRUARY 1, 2023
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections zbecker Wed, 02/01/2023 - 19:49
Fierce Pharma
FEBRUARY 1, 2023
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections zbecker Wed, 02/01/2023 - 19:49
MedCity News
FEBRUARY 1, 2023
GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users’ data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 1, 2023
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback aliu Wed, 02/01/2023 - 13:57
MedCity News
FEBRUARY 1, 2023
Instead of leaning on the arbitrary and subjective nature of prominent, perceived prestige-focused industry rankings, health systems must shift to a data-driven and mathematically sound approach to determining and benchmarking quality.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
FEBRUARY 1, 2023
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex kdunleavy Wed, 02/01/2023 - 10:19
MedCity News
FEBRUARY 1, 2023
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
FEBRUARY 1, 2023
Russian hacker group Killnet has claimed responsibility for a string of recent cyberattacks that took more than a dozen hospital websites offline across the U.S. — including the websites for Cedars-Sinai, Michigan Medicine, and UPMC. The group has been active for at least a year and is known to target countries that support and/or send resources to Ukraine.
Fierce Pharma
FEBRUARY 1, 2023
Amgen aims to make the most of Amjevita's head start amid broader biosim lull, Lumakras miss fkansteiner Wed, 02/01/2023 - 09:44
Pharmaceutical Technology
FEBRUARY 1, 2023
Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. On an operational basis, the revenues rose by 5%, omitting contributions from Paxlovid and Comirnaty.
Fierce Pharma
FEBRUARY 1, 2023
GSK, after consumer spinoff, touts momentum for core products Cabenuva and Shingrix esagonowsky Wed, 02/01/2023 - 09:23
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
FEBRUARY 1, 2023
Security threats are not going away any time soon. In fact, they are on the rise and likely will be for years to come. Here are three ways to solve the most pressing problems.
Fierce Pharma
FEBRUARY 1, 2023
Novartis' Zolgensma, Leqvio lag among new launches as Entresto and Pluvicto steam ahead aliu Wed, 02/01/2023 - 10:33
European Pharmaceutical Review
FEBRUARY 1, 2023
A recent market report showed that the global pharmaceutical sterility testing market is expected to grow from $2.07 billion in 2027 at a compound annual growth rate (CAGR) of 12.5 percent. The global pharmaceutical sterility testing market grew from $1.19 billion in 2022 to $1.29 billion in 2023 at a CAGR of 8.9 percent. An increase in the number of drug launches and rising investment in R&D contributed to the growth of the market, found the Business Research Company, who produced the repor
Pharma Pathway
FEBRUARY 1, 2023
Macleods Pharmaceuticals Ltd.- Walk-In Interviews for Freshers in Production-Formulation On 5th Feb’ 2023 Job Description Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Copyright Clearance Center
FEBRUARY 1, 2023
February 1, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced key findings from the just released “ Information Seeking and Consumption Study ” based on data gathered by Outsell, Inc., the voice of the data, information and analytics industry. According to results from the most recent study, potential instances of unlicensed sharing per employee in the executive suite was significantly higher than middle management or
PharmaTimes
FEBRUARY 1, 2023
UK-wide therapy for patients who have seizures linked to tuberous sclerosis complex
Pharma Pathway
FEBRUARY 1, 2023
Sun Pharma- Openings for Freshers & Experienced in Engineering Dept. -Apply Now Job Description: Openings for Freshers & Experienced in Engineering Dept. -Apply Now @ Sun Pharma Department: Engineering Designation: Apprentice Qualification: B.Tech/ B.E/ Diploma Experience: 0 to 1 years Job Location: Indore, Dewas, Pithampur Salary: ₹ 1,00,000- 2,25,000 P.A.
PharmaTimes
FEBRUARY 1, 2023
Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharma Pathway
FEBRUARY 1, 2023
Bharat Parenterals Limited-Walk-In Interviews for Production/ Packing On 4th Feb’ 2023 Job Description Bharat Parenterals Limited is a Gujarat based pharmaceutical Company , established in 1992 by Mr. Ramesh Desai, who started the Company with a vision of making world class affordable medicines in Gujarat. Walk-In Interviews for Production-Tablet / Capsules, Injectables, Packing On 4th Feb’ 2023 @ Bharat Parenterals Limited Department : Production/ Packing Qualification: B.Pharm/ M.
Eversana Intouch
FEBRUARY 1, 2023
“Let’s raise the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the ‘right message at the right time’ to drive meaningful results that wouldn’t otherwise be realized by traditional sales and marketing strategies? Are those ‘seamless brand experiences’ integrating the right mix of digital tools and one-on-one personal engagements actually accelerating patients’ time to therapy and delive
Contrarian Sales Techniques
FEBRUARY 1, 2023
Finding suppliers for alternative milk options like almond, soy, and oat milk can be done both online and offline. Here are some tips for finding suppliers for alternative milk options : Online Marketplaces : Online marketplaces such as Amazon, Alibaba, and eBay are great places to start looking for suppliers of alternative milk options. You can easily search for the products you want and compare prices and quality from different suppliers.
Clarify Health
FEBRUARY 1, 2023
Life sciences companies use real-world evidence (RWE) to make key decisions throughout a therapy’s life cycle — from research and development (R&D) to clinical trials to commercial operations. Pfizer and Boehringer Ingelheim have built centers of excellence (CoEs) to accelerate the use of real-world data and real-world evidence across their organizations.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Contrarian Sales Techniques
FEBRUARY 1, 2023
I would say that success and satisfaction are often seen as being linked, but in reality, they are two separate things. Success can bring temporary happiness and a sense of accomplishment, but it doesn't necessarily lead to long-term satisfaction. Satisfaction comes from within and is a sense of contentment and fulfillment in life, regardless of external circumstances.
Pharma Pathway
FEBRUARY 1, 2023
Mylan Laboratories Ltd-Openings for B.Pharm/ M.Pharm/ M.Sc/ B.Sc for QA -Officer-Apply Now Job Description Openings for B.Pharm/ M.Pharm/ M.Sc/ B.Sc in QA -Officer @ Mylan Laboratories (Viatris) Officer- QA (Document Cell) Department: QA -Officer Qualification: B.Pharm/ M.Pharm / M.Sc/ B.Sc Experience: 01 to 05+ years Location: Ahmedabad Contact: Bhavik Parekh HR Please Mention in Subject “CV for – QA (Doc Cell)” And Send CV On bhavik.parekh@viatris.com Mylan Laboratories Ltd-Openings
Contrarian Sales Techniques
FEBRUARY 1, 2023
After reading the "sales strategy for milk products" article , I learned some valuable insights that I believe can be applied to any industry, not just the milk product industry. Here's what stood out to me the most: Know your audience : One of the key points that the article highlighted is the importance of understanding your target market. In the case of milk products, the article emphasized the need to understand the specific needs and preferences of different demographics, such as families w
Pharma Pathway
FEBRUARY 1, 2023
Macleods Pharmaceuticals -Walk-In Interviews for Production/ QC/ QA On 12th Feb’ 2023 Job Description Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries. Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Contrarian Sales Techniques
FEBRUARY 1, 2023
I recently come across the article " Banking SalesTechniques " and found it to be incredibly informative. As a salesperson for a bank, it is important to stay up-to-date with the latest techniques and strategies for achieving success in the industry. This article provided several valuable insights that I believe will be extremely beneficial in helping me meet my sales goals.
Copyright Clearance Center
FEBRUARY 1, 2023
From Research and Industry News to Workforce Trends and Legislative Reform, Organizations Rely on the Reuse of Published Content to Support Collaboration and Drive Innovation CCC today announced key findings from the just released “ Information Seeking and Consumption Study ” based on data gathered by Outsell, Inc., the voice of the data, information and analytics industry.
Contrarian Sales Techniques
FEBRUARY 1, 2023
"The Science of Getting Rich" It's a book written by Wallace D. Wattles in 1910 that provides a philosophical approach to personal wealth and financial success. The book lays out the principles of how to think and act to acquire wealth and success. Gratitude is a crucial component of the "Science of Getting Rich." The author emphasizes the importance of having a grateful mindset and counting one's blessings in order to attract more abundance and positive experiences into one's life.
Pharma Pathway
FEBRUARY 1, 2023
Jodas Expoim Pvt. Ltd- Walk-In Interview for Quality Control/ Production -Injectable On 3rd Feb’ 2023 Job Description Walk-In Interview for Quality Control/ Production -Injectable On 3rd Feb’ 2023 @ Jodas Expoim Pvt. Ltd Department: Quality Control (Injectable)/ Production (Injectable) Qualification: B.Pharmacy/ M.Pharmacy / ITI/ M.Sc Microbiology Experience: 1 to 6 years Designation: Executive/ Operator Date: 3rd Feb’ 2022 Time: 09:00 AM to 12:00 PM Venue: Jodas Expoim Pvt.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content